Page 13 - Ioscience News Today

Developed and manufactured in collaboration with US-based Prime Bio

KELOWNA, BC / ACCESSWIRE / December 29, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce its

KELOWNA, BC / ACCESSWIRE / December 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it

San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the p

Polytaxel, a novel pain-free anticancer drug, may not require break periodsA new standard of care, more convenient than docetaxel, is suggestedHyundai Bioscience to enter clinical trial on pancreatic

Seoul [South Korea], November 24 (ANI/Global Economic): SK Bioscience on Wednesday said that it is not producing finished products of Koreas first COVID-19 vaccine Sky Covione due to its low vaccination rate.

Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Cell Counting Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By...

Sintalica Bioscience Corp. ("Sintalica" or the "Company"), a psychedelic drug discovery company focused on breakthrough treatments for neuroinflammatory disorders, today announced that the Company has

Toronto, Ontario--(Newsfile Corp. - November 23, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a drug discovery company developing therapeutics to regenerate muscle

San Diego, California--(Newsfile Corp. - November 22, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative